Does Rallies show 13F holders for ANGO?

Yes. Rallies tracks hedge fund and 13F ownership data for ANGO, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ANGO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ANGO. It does not provide personalized investment advice.

ANGO (AngioDynamics, Inc.) Stock Analysis - Hedge Fund Holdings

AngioDynamics, Inc. (ANGO) is a publicly traded Healthcare sector company. As of May 21, 2026, ANGO trades at $11.80 with a market cap of $457.40M and a P/E ratio of -15.46. ANGO moved +3.15% today. Year to date, ANGO is -10.73%; over the trailing twelve months it is +24.19%. Its 52-week range spans $5.83 to $13.99. Analyst consensus is strong buy with an average price target of $16.00. Rallies surfaces ANGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ANGO stock?

Hedge funds tracked by Rallies that own ANGO include Panagora Asset and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AngioDynamics, Inc..

ANGO Key Metrics

Key financial metrics for ANGO
Metric	Value
Price	$11.80
Market Cap	$457.40M
P/E Ratio	-15.46
EPS	$-0.76
Dividend Yield	0.00%
52-Week High	$13.99
52-Week Low	$5.83
Volume	341.93K
Avg Volume	0
Revenue (TTM)	$313.73M
Net Income	$-31.39M
Gross Margin	54.30%

Top Hedge Funds Holding ANGO

Panagora Asset holds 250.21K shares of ANGO, changed +35.89% as of Mar 31, 2026.
Pinebridge Investments holds 1.23K shares of ANGO, changed +0.00% as of Jun 30, 2023.

Latest ANGO News

AngioDynamics Down 5.8% with RSI at 9.16 as EPS Estimates Rise 24.1% — Apr 11, 2026
AngioDynamics Raises Sales Guidance Again, EPS Loss Range $0.30 to $0.23 — Apr 2, 2026
AngioDynamics Q3 Revenue Rises 8.9% to $78.4M, EPS Misses Estimates — Apr 2, 2026
Veeva Systems Q4 EPS Rises 18.4% to $2.06; Revenues Hit $836M — Mar 5, 2026
AngioDynamics Expands NanoKnife EU Indications and Schedules Leerink Presentation — Feb 23, 2026

Recent ANGO Insider Trades

Weiss Lawrence T bought 10.00K (~$118.10K) on Oct 21, 2025.
Trowbridge Stephen A bought 890 (~$9.93K) on Oct 13, 2025.
Clemmer James C bought 10.00K (~$111.50K) on Oct 9, 2025.

ANGO Analyst Consensus

3 analysts cover ANGO: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.00.

Common questions about ANGO

Who owns ANGO stock?: Hedge funds tracked by Rallies that own ANGO include Panagora Asset and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for AngioDynamics, Inc..
Does Rallies show 13F holders for ANGO?: Yes. Rallies tracks hedge fund and 13F ownership data for ANGO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ANGO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ANGO. It does not provide personalized investment advice.